Balance Sheet Data

MacroGenics, Inc. (MGNX)

$8.93

+0.29 (+3.36%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 232.86215.76272.53243.62154.35588.70793.311,069.031,440.601,941.30
Total Cash (%)
Account Receivables 29.5812.7423.0810.3956.2259.0179.52107.15144.40194.58
Account Receivables (%)
Inventories ---4.391.456.929.3212.5616.9322.81
Inventories (%)
Accounts Payable 4.014.318.0315.504.9018.6525.1333.8645.6361.49
Accounts Payable (%)
Capital Expenditure -24.95-4.29-5.91-6.20-3.62-26.64-35.89-48.37-65.18-87.84
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.